Australian Legislators Debate Whether To Ease Restrictions On Producing Generic Drugs For Export
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The Australian government is mulling whether to allow local manufacturers to produce generic versions of drugs that are still under patent protection inside the country for export to markets in which patents have expired